Provectus Biopharmaceuticals (PVCT) Notes Payables (2017 - 2026)
Provectus Biopharmaceuticals (PVCT) reported Notes Payables of $92,443 for Q2 2026, up 70.1% from $54,337 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Notes Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Provectus Biopharmaceuticals posted Notes Payables of $217,772, up 5.5% from FY2024.
- Notes Payables has a five-year compound annual growth rate of -58.0% (FY2020 to FY2025).
- By year, Notes Payables came in at $206,463 in FY2024 (-25.7%), $277,815 in FY2023 (-55.5%), $625,000 in FY2022 (-50.4%) and $1.26 million in FY2021 (-92.4%).
- Five-year quarterly Notes Payables spans a low of $54,337 in Q2 2025 and a high of $1.81 million in Q3 2022.
- Year over year, Notes Payables gained in two of the last seven quarters, with an average decline of 17.9%.
- The high point for year-over-year Notes Payables in five years was Q3 2022 (growth of 805.0%); the low point was Q3 2021 (a decline of 98.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92,443.00 |
| Dec 31, 2025 | 217,772.00 |
| Sep 30, 2025 | 105,860.00 |
| Jun 30, 2025 | 54,337.00 |
| Mar 31, 2025 | 124,578.00 |
| Dec 31, 2024 | 206,463.00 |
| Sep 30, 2024 | 110,544.00 |
| Jun 30, 2024 | 109,862.00 |
| Mar 31, 2024 | 190,910.00 |
| Dec 31, 2023 | 277,815.00 |
| Sep 30, 2023 | 775,000.00 |
| Jun 30, 2023 | 148,273.00 |
| Mar 31, 2023 | 575,000.00 |
| Dec 31, 2022 | 625,000.00 |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 17.85 Mn |
API Access
Provectus Biopharmaceuticals Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();